Cibc Asset Management Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Cibc Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$0.28 - $1.16 $5,724 - $23,713	20,443 Added 81.38%	45,563 $15,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $7,442 - $13,582	-6,202 Reduced 19.8%	25,120 $33,000
Q4 2022 Feb 13, 2023	SELL	$1.63 - $3.52 $72,293 - $156,119	-44,352 Reduced 58.61%	31,322 $52,000
Q2 2022 Aug 09, 2022	SELL	$2.2 - $4.2 $12,185 - $23,263	-5,539 Reduced 6.82%	75,674 $180,000
Q4 2021 Feb 08, 2022	BUY	$8.31 - $14.92 $674,880 - $1.21 Million	81,213 New	81,213 $675,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.